Acquisitions23 Jul 2025, 04:12 pm
Natco Pharma Acquires 35.75% Stake in Adcock Ingram Holdings Limited for Rs.2000 Crores
AI Summary
Natco Pharma Ltd. has announced the outcome of its Board Meeting held on 23rd July, 2025. The company has approved the acquisition of 51,643,319 shares of Adcock Ingram Holdings Limited, a South African pharmaceutical company. The acquisition includes 5,03,51,444 ordinary shares from the public and 12,91,875 treasury shares/fresh issuance from Adcock Ingram Holdings Limited. The total investment cost, including transaction cost and other expenses, is approximately Rs.2000 crores. The acquisition aims to expand Natco's geographic footprint in South Africa and increase profitability.
Key Highlights
- Natco Pharma to acquire 35.75% stake in Adcock Ingram Holdings Limited for approximately Rs.2000 crores
- The acquisition includes 5,03,51,444 ordinary shares from the public and 12,91,875 treasury shares/fresh issuance from Adcock Ingram Holdings Limited
- The transaction is expected to be completed by the end of December 31, 2025
- The acquisition aims to expand Natco's geographic footprint in South Africa and increase profitability
- The proposed transaction is subject to regulatory approvals from the Reserve Bank of India, South Africa’s Takeover Regulation Panel (TRP), and the South African Reserve Bank (SARB)